135 related articles for article (PubMed ID: 19829178)
1. The emerging role of apelin in cardiovascular disease and health.
Quazi R; Palaniswamy C; Frishman WH
Cardiol Rev; 2009; 17(6):283-6. PubMed ID: 19829178
[TBL] [Abstract][Full Text] [Related]
2. The role of apelin in cardiovascular function and heart failure.
Chandrasekaran B; Dar O; McDonagh T
Eur J Heart Fail; 2008 Aug; 10(8):725-32. PubMed ID: 18583184
[TBL] [Abstract][Full Text] [Related]
3. The apelin-APJ system in heart failure: pathophysiologic relevance and therapeutic potential.
Japp AG; Newby DE
Biochem Pharmacol; 2008 May; 75(10):1882-92. PubMed ID: 18272138
[TBL] [Abstract][Full Text] [Related]
4. Renin-angiotensin-aldosterone system for blood pressure and electrolyte homeostasis and its involvement in hypertension, in congestive heart failure and in associated cardiovascular damage (myocardial infarction and stroke).
Laragh JH
J Hum Hypertens; 1995 Jun; 9(6):385-90. PubMed ID: 7473515
[TBL] [Abstract][Full Text] [Related]
5. Jacques Benoit lecture: the neuroendocrine view of the angiotensin and apelin systems.
Llorens-Cortes C; Kordon C
J Neuroendocrinol; 2008 Mar; 20(3):279-89. PubMed ID: 18194430
[TBL] [Abstract][Full Text] [Related]
6. Apelin: a novel neurohumoral modulator of the cardiovascular system. Pathophysiologic importance and potential use as a therapeutic target.
Falcão-Pires I; Leite-Moreira AF
Rev Port Cardiol; 2005 Oct; 24(10):1263-76. PubMed ID: 16398242
[TBL] [Abstract][Full Text] [Related]
7. Apelin in acute myocardial infarction and heart failure induced by ischemia.
Tycinska AM; Lisowska A; Musial WJ; Sobkowicz B
Clin Chim Acta; 2012 Feb; 413(3-4):406-10. PubMed ID: 22146598
[TBL] [Abstract][Full Text] [Related]
8. The apelinergic system: the role played in human physiology and pathology and potential therapeutic applications.
Ladeiras-Lopes R; Ferreira-Martins J; Leite-Moreira AF
Arq Bras Cardiol; 2008 May; 90(5):343-9. PubMed ID: 18516406
[TBL] [Abstract][Full Text] [Related]
9. [Effect of apelin in cardiovascular system and water metabolism].
Corvol P
Therapie; 2009; 64(4):233-9. PubMed ID: 19804703
[TBL] [Abstract][Full Text] [Related]
10. Vascular effects of apelin in vivo in man.
Japp AG; Cruden NL; Amer DA; Li VK; Goudie EB; Johnston NR; Sharma S; Neilson I; Webb DJ; Megson IL; Flapan AD; Newby DE
J Am Coll Cardiol; 2008 Sep; 52(11):908-13. PubMed ID: 18772060
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II AT2 subtype receptors: an emerging target for cardiovascular therapy.
Volpe M; De Paolis P
Ital Heart J; 2000 Feb; 1(2):96-103. PubMed ID: 10730608
[TBL] [Abstract][Full Text] [Related]
12. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
13. RAA system and cardiovascular control in normal subjects, hypertensives and patients with congestive heart failure.
Seravalle G; Cattaneo BM; Giannattasio C; Perondi R; Saino A; Grassi G; Mancia G
J Hum Hypertens; 1993 Aug; 7 Suppl 2():S13-8. PubMed ID: 8230084
[TBL] [Abstract][Full Text] [Related]
14. Sustained cardiovascular actions of APJ agonism during renin-angiotensin system activation and in patients with heart failure.
Barnes GD; Alam S; Carter G; Pedersen CM; Lee KM; Hubbard TJ; Veitch S; Jeong H; White A; Cruden NL; Huson L; Japp AG; Newby DE
Circ Heart Fail; 2013 May; 6(3):482-91. PubMed ID: 23519586
[TBL] [Abstract][Full Text] [Related]
15. The renin-angiotensin system in heart failure.
Cleland JG
Herz; 1991 Apr; 16(2):68-81. PubMed ID: 2066055
[TBL] [Abstract][Full Text] [Related]
16. Unravelling the roles of the apelin system: prospective therapeutic applications in heart failure and obesity.
Lee DK; George SR; O'Dowd BF
Trends Pharmacol Sci; 2006 Apr; 27(4):190-4. PubMed ID: 16530855
[TBL] [Abstract][Full Text] [Related]
17. [Vasoactive polypeptides and cardiovascular endocrine diseases].
Zeng ZP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Aug; 27(4):443-5. PubMed ID: 16178436
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin receptor blockers: novel role in high-risk patients.
Javed U; Deedwania PC
Cardiol Clin; 2008 Nov; 26(4):507-26. PubMed ID: 18929228
[TBL] [Abstract][Full Text] [Related]
19. [Renin-angiotensin system and its role in cardiovascular physiopathology and therapy].
Castro-Chaves P; Leite-Moreira AF
Rev Port Cardiol; 2004 May; 23 Suppl 2():II61-77. PubMed ID: 15222251
[TBL] [Abstract][Full Text] [Related]
20. Apelin and visfatin: unique "beneficial" adipokines upregulated in obesity?
Bełtowski J
Med Sci Monit; 2006 Jun; 12(6):RA112-9. PubMed ID: 16733497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
